Search PubMed⌕ Search

Biomedical subjects

F X Roux

Publications and source records attributed to F X Roux.

At least 37 records · Page 2Linked to original sources
PubMed1998

[Use of endoscopy in pituitary surgery].

Endoscopy has changed many of surgical procedures concerning nasal and paranasal cavities. It has been proposed for transnasal removal of pituitary adenomas. The authors report their experience concerning four pituitary macroadenomas operated with the neurosurgical team of Sainte-Anne hospital. The endonasal trans-septal route seemed to be more anatomical and less traumatic than the rhinoseptal sublabial route. The 30 degrees rigid Hopkins endoscope was a good help for controlling the absence of any tumor remnant in the supra and parasellar regions after complete removal of the tumor performed through the endoscope or with the operating microscope. The authors discuss the advantages and limitations of such endoscopic procedures in the light of recent literature.

Adenoma↗
PubMed1998

[The place of radiosurgery in the treatment of hypophyseal adenoma].

Since 1984, the neurosurgical team of Sainte-Anne Hospital in Paris has taken in charge almost 750 patients for linear accelerator radiosurgery. But only a small percentage of them were harbouring a pituitary tumor. That is why the present paper is based mostly on literature data. Pituitary adenoma radiosurgery (RS) is a second intention therapeutic method. It should be recommended only after failure of medical and/or surgical treatment. Two main methods can be used: linear accelerator-radiosurgery and Cobalt-60 gamma unit. Both procedures provide equivalent results in terms of dosimetry, accuracy and clinical data. Results of various series presented in recent and updated literature have been studied and analysed. They show and confirm the efficiency of radiosurgery on tumor and hormone secretion controls, with few cases of pituitary insufficiency. However, results were disappointing concerning visual disorders, particularly if visual dysfunction and impairment existed before radiosurgery. All authors agree nowadays on different points: a) indications: invasive adenomas, with an incomplete resection, or adenomatous recurrences, b) contraindications: tumoral size > 20 mm, distance to visual pathways < 5 mm, c) imperative precautionary measures: less than 8 Gray must be delivered on visual pathways, less than 40 Gray on oculomotor nerves. In some cases, stereotactic fractioned radiotherapy may be an alternative treatment for large tumors close to visual pathways.

Adenoma↗
PubMed1998

[Intracavernous extension of hypophyseal macroadenomas: infiltration or invagination?].

Frequency of intracavernous invasion by a pituitary adenoma varies from 9% to 40% depending on the publications. Without putting off the possibility of true intracavernous invasion, it seems less frequent than evocated on CT-Scan and/or MRI data. We studied 153 files of pituitary adenomas operated upon recently: 72 prolactinomas (47.3%), 30 GH-secreting adenomas (19.7%), 7 corticotrop adenomas (4.6%), 44 non secreting adenomas (28.3%). 108 patients (70.4%) harboured a macroadenoma (diameter > 10 mm). A suprasellar expansion was seen 90 times on CT-Scan and/or MRI views. 19 times (17.7% of macroadenomas, 12.5% of the whole series) MRI evocated an infiltration of one or both cavernous sinuses (CS). Such data were found 3 times before 1991, 16 times since 1991, i.e. since MRI is systematically performed preoperatively. Except in two patients who respectively presented with a large intraorbital or temporal expansion, we have not been able to confirm the reality of the intracavernous invasion. We think that most of CT-Scan or MRI data of so-called intracavernous invasion correspond in fact to a compression or to a fingerglove invagination of the medial wall of the CS. In fact, anatomical studies by Harris & Rhoton (1976) and by Taptas (1990) demonstrated that such an invagination of the medial wall exists in almost one third of normal pituitary glands. These data must bring up to much carefulness when considering a possible pathological CS invasion by a macroadenoma. Therefore, it should be thoroughly assessed with anatomoradiological and radio-surgical correlations.

Adenoma↗
PubMed1998

[Controversies in the management of operated pituitary macroadenomas].

BACKGROUND AND PURPOSE: Complete resection of a pituitary adenoma is feasible in almost 50 to 70% of cases. Dealing with the remnant is still controversial. Three positions can be discussed: second stage operation, radiation therapy, clinical and radiological follow-up. METHODS: Among 108 pituitary macroadenomas operated on during the last 10 years, 54 patients (50%) with partially removed tumors were studied. Three cases best illustrating the evolution of these remnants are reported. RESULTS: Late MRI performed 4 to 6 months postoperatively is more valuable than early MRI in the evaluation of these remnants, which can remain stable for a long period of time without any adjuvant treatment. CONCLUSION: MRI should be performed 4 to 6 months postoperatively. Rather than performing radiation therapy systematically for asymptomatic patients, these patients should be followed up at regular intervals and treated only in case of regrowth of the tumor.

Adenoma↗
PubMed1997

Angioarchitecture associated with haemorrhage in cerebral arteriovenous malformations: a prognostic statistical model.

The overall haemorrhagic risk of a cerebral arteriovenous malformation (cAVM) is 2-4% per year. However, the individual risk of haemorrhage has never been determined. This study was undertaken to assess the haemorrhage risk of an individual cAVM. Neuroangiographic findings of 160 cAVM were analysed retrospectively, looking at 30 angiographic features. A statistical model was established by logistic regression to evaluate the risk of an individual cAVM. We statistically correlated 15 parameters with the haemorrhage risk. The statistical model includes five independent parameters. Four are unfavourable: exclusively deep drainage, venous stenoses, venous reflux and the radio of afferent to efferent systems; one is favourable: venous recruitment. This model quantifies the individual risk of haemorrhage. When this model is applied to the population studied, the error rate is 5%. This model can contribute to therapeutic strategy, and to a better understanding of the natural history of cAVM.

Adolescent↗
PubMed1997

Parenchymal changes after radiosurgery of cerebral arteriovenous malformations. Preliminary report of a proposed classification.

Radiosurgery of cerebral arteriovenous malformations (cAVM) can induce parenchymal changes seen on MRI. The purpose of this study was to classify these changes and to correlate them to clinical outcome and obliteration of the cAVM. 142 patients with cAVM underwent radiosurgery with a linear accelerator between 1994 and 1995. 60 clinical records, MR images, and postradiation angiograms were reviewed. Signal abnormalities and contrast enhancements were correlated with clinical deterioration and size decrease of the AVM. The Spearman nonparametric test was used for statistical correlation. MR findings allowed to differentiate between four grades: grade 1 = no parenchymal changes; grade 2 = hypersignal on T2-weighted sequences, grade 3 = grade 2 + contrast enhancement on T1-weighted sequences; grade 4 = grade 3 + central hyposignal (necrosis-like) + peripheral hyposignal surrounding the AVM on T1-weighted sequences. Grade 4 was significantly related (p < 0.001) to clinical deterioration (deficit, seizures, increased intracranial pressure). All grade 4 patients, and only them, had clinical symptoms. Most of these symptoms regressed with corticoid treatment. Grade 4 was also related to the proportion of obliteration of the cAVM at 1 year after radiotherapy: mean proportion of obliteration was 12.5% for grade 2, 25% for grade 3 and 82.2% for grade 4 (p < 0.01). The size of T2-weighted MR images was related to clinical symptom appearance (p < 0.001). Finally, contrast enhancement was not predictive of the occurrence of the clinical symptoms. This proposed classification allows one to differentiate between the various MR images, and seems to predict clinical complications and response to radiotherapy of the cAVM.

Brain↗
PubMed1997

[Trans-facial approaches of cancers of the ethmoid].

Lateral rhinotomy, midface degloving approach and medial maxillectomy are described. Lateral rhinotomy allows for a wide surgical approach, complete tumor removal with safe margins and satisfying cosmetic result. Lateral rhinotomy with medial maxillectomy is recommended for surgical resection of ethmoid sinus carcinoma. This surgical approach allows for a simultaneous neurosurgical subfrontal approach.

Ethmoid Sinus↗
PubMed1997

[Malignant tumors of the ethmoid region. Neurosurgical techniques].

We describe the main neurosurgical approaches in use for removing cancers of the ethmoid region: a) the classical subfrontal procedure usually combined with a transfacial approach, b) the sub-fronto-orbito-nasal approach (SFON) now performed in a majority of procedures as long as the tumor does not present with a large intra-cranial and/or maxillary extension. The advantages and drawbacks of both techniques are discussed. The progressive simplification of techniques for anterior cranial base reconstruction is explained and warranted.

Ethmoid Bone↗
PubMed1997

[Malignant ethmoid-sphenoidal tumors. 130 cases. Retrospective study].

We report on 130 ethmoidal cancers. 96 (74%) were adenocarcinomas (ADKE). 110 were operated upon between 1984 and 1996: 9.1% T1 + T2, 27.7% T3, 36.2% T4a, 27% T4b. Neoadjuvant chemotherapy was administered in 93 patients (76 ADKE). Combined surgical route was performed 103 times, sub-fronto-orbito-nasal (SFON) route 7 times. Post-operative radiotherapy was performed in 36 patients. Complete clinical and radiological response to chemotherapy was noted in 21.5% of cases (23% of ADKE). Post-operative mortality concerned one patient who died from a pulmonary embolism during the third post-operative week. Morbidity included: 3 transient clinical rhinorrheas, 5 meningitis (one of which was responsible for heavy psycho-intellectual disability), 4 deep suppurations associated with osteitis of the bone flap and two superficial suppurations. 44 patients had a local recurrence (10 ADKE). No recurrence appeared in complete chemoresponders. Systematic preservation of intra-orbital contents did not increase the risk of local failure. Eleven patients (4 ADKE) developed cervical nodes and/or systemic metastasis. Death occurred after a mean of three months following the diagnosis of metastasis. Survival rate was: 60% at 3 years, 51.5% at 5 years, 32.5% at 10 years. ADKE survival rate was: 55% at 3 years, 51.5% at 5 years, 23% at 10 years. Survival ws related to tumoral extension: 75% at 5 and 10 years for T3, 45% at 5 years and 38% at 10 years for T4a, 40% at 3 years and null at 5 years for T4b, 5 and 10 years survival rate of complete chemoresponders are 100% whatever the tumour. Prognosis remained poor for epidermoid carcinomas (survival rate: 36% at 3 years, 0% at 5 years) and for melanomas (mean survival: 19.6 months). Post-operative radiotherapy should be indicated for large tumors T3, T4a and T4b).

Adenocarcinoma↗
PubMed1997

[Stereotaxic technics and clinical neurosurgery].

Stereotactic methodology developed at Sainte-Anne Hospital Center from 1947 is based on the application of a simple spatial geometry-the Talairach Ac-Pc reference system-to the cranial volume and the identification of any anatomical structure or brain lesion within this volume. Now upgraded with modern imaging techniques, this methodology is the ground for multiple applications in functional as well as lesional neurosurgery and is now a a part of the daily neurosurgical practice at Sainte-Anne Hospital. Stereotactic procedures include three steps: first, the identification of one or several target-volumes through stereotactic imaging acquisition: CT, MRI and conventional stereoscopic angiography; second, the image treatment on a dedicated workstation for stereotactic coordinates determination and surgical planning; third, the surgical procedure itself and its control. The most frequent applications for stereotactic methodology are: image-guided stereotactic biopsies of brain tumors, in order to obtain tissue pathological diagnosis and spatial configuration; linac-based radiosurgery of arterio-venous malformations and tumors with high energy collimated beams converging towards a simple or complex target volume; surgery for partial drug-resistant epilepsy including depth electrode implantation for stereo-electroencephalography and epileptogenic cortex resection; stereotactic image-guided resection of superficial or deep-seated tumors or vascular malformation; Rhenium 186 intracavitary irradiation of cystic tumors such as craniopharyngiomas.

Biopsy↗
PubMed1996

Cisplatin-based neoadjuvant chemotherapy and combined resection for ethmoid sinus adenocarcinoma reaching and/or invading the skull base.

OBJECTIVE: To review our experience with cisplatin-based neoadjuvant chemotherapy before en bloc resection via a combined neurosurgical and transfacial approach for ethmoid sinus adenocarcinoma reaching and/or invading the skull base. DESIGN: Case series. SETTING: A tertiary care center and university teaching hospital. PATIENTS: Twenty-two patients with primary untreated ethmoid sinus adenocarcinoma reaching and/or invading the skull base consecutively treated between 1984 and 1992 with cisplatin-based neoadjuvant chemotherapy and combined neurosurgical and transfacial approach. MAIN OUTCOME MEASURES: Statistical analysis of survival, local control, nodal recurrence, distant metastasis, and metachronous second primary tumor incidence based on the Kaplan-Meier actuarial method. Univariate analysis was performed to analyze the relationships between various factors, survival, and local recurrence. Clinical response, histological response, toxic effects of chemotherapy, and postoperative course were also reported. RESULTS: The Kaplan-Meier 3-year survival, local control, nodal recurrence, and distant metastasis estimates were 68.1%, 65.7%, 5.3%, and 10%, respectively. Metachronous second primary tumor was not encountered in our series. Survival was statistically more likely to be reduced in patients with intrasphenoidal tumor extent (P = .04) and local recurrence (P = .01). Local recurrence was statistically more likely in patients with intrasphenoidal tumor extent (P = .002) and no response to cisplatin-based neoadjuvant chemotherapy (P = .03). CONCLUSIONS: The results achieved suggest that cisplatin-based neoadjuvant chemotherapy before combined neurosurgical and transfacial approach should be further investigated for the treatment of ethmoid sinus adenocarcinoma reaching and/or invading the skull base.

Adenocarcinoma↗
PubMed1996

Interstitial laser thermotherapy in neurosurgery: a review.

One of the most recent laser treatment modalities in neurosurgery is interstitial laser thermotherapy (ILTT). In this review, experimental and clinical studies concerning intracranial ILTT are discussed. Two methods for intra-operative control of the laser induced lesions are described; i.e., computer-controlled power delivery, using a thermocouple that is positioned interstitially at the periphery of the tumour to maintain the desired temperature at that point, and MRI, to visualise the extent of the thermal lesions induced by ILTT. The results show that ILTT using a Nd: YAG laser is easy and relatively effective in the treatment of small deep-seated brain tumours with minimal risk and complications. This review is concluded with suggestions for further improvement of this treatment modality.

Animals↗
PubMed1996

Experimental and clinical standards, and evolution of lasers in neurosurgery.

From initial experiments of ruby, argon and CO2 lasers on the nervous system so far, dramatic progress was made in delivery systems technology as well as in knowledge of laser-tissue interaction effects and hazards through various animal experiments and clinical experience. Most surgical effects of laser light on neural tissue and the central nervous system (CNS) are thermal lesions. Haemostasis, cutting and vaporization depend on laser emission parameters--wavelength, fluence and mode--and on the exposed tissues optical and thermal properties--water and haemoglobin content, thermal conductivity and specific heat. CO2 and Nd-YAG lasers have today a large place in the neurosurgical armamentarium, while new laser sources such as high power diode lasers will have one in the near future. Current applications of these lasers derive from their respective characteristics, and include CNS tumour and vascular malformation surgery, and stereotactic neurosurgery. Intracranial, spinal cord and intra-orbital meningiomas are the best lesions for laser use for haemostasis, dissection and tissue vaporization. Resection of acoustic neuromas, pituitary tumours, spinal cord neuromas, intracerebral gliomas and metastases may also benefit from lasers as accurate, haemostatic, non-contact instruments which reduce surgical trauma to the brain and eloquent structures such as brain stem and cranial nerves. Coagulative lasers (1.06 microns and 1.32 microns Nd-YAG, argon, or diode laser) will find an application for arteriovenous malformations and cavernomas. Any fiberoptic-guided laser will find a use during stereotactic neurosurgical procedures, including image-guided resection of tumours and vascular malformations and endoscopic tumour resection and cysts or entry into a ventricle. Besides these routine applications of lasers, laser interstitial thermotherapy (LITT) and photodynamic therapy (PDT) of brain tumours are still in the experimental stage. The choice of a laser in a neurosurgical operating room implies an evaluation of the laser use (applications, frequency), of the available budget and costs--including purchase, maintenance and staff training--, and material that will be necessary: unit, peripherals, safety devices and measures, training programme. Future applications of lasers in neurosurgery will come from technological advances and refined experimental applications. The availability of new wavelength, tunable, small sized and "smart" laser units, will enlarge the thermal and non-thermal interactions between laser energy and neural tissue leading to new surgical applications. Tissue photo-ablation, photohynamic therapy using second generation of photosensitizers, updated thermotherapy protocols, are current trends for further use of lasers in neurosurgery.

Animals↗
PubMed1996

Intraspinal meningiomas: review of 54 cases with discussion of poor prognosis factors and modern therapeutic management.

INTRODUCTION: Intraspinal meningiomas account for 25%-46% of primary spinal cord tumors. Technical advances in magnetic resonance imaging (MRI) and surgical procedures (ultrasonic cavitation aspirators [CUSA], lasers) have brought about better clinical results. In spite of these new techniques, a small percentage of patients still present with poor postoperative results and/or a recurrence. The authors tried to determine which data could influence clinical outcome and what therapeutic modalities could limit recurrence rate. MATERIALS AND METHODS: We reviewed 54 patients who from 1963 to 1994, each had surgery for an intraspinal meningioma. There were 43 females and 11 males, aged 8 to 85 years old. Thirty-six (66.6%) patients were ambulatory on admission; only 2 presented with a paraplegia. Tumor location was cervical in 10 cases, thoracic in 43 cases, lumbar in 1 case. Forty-seven tumors were intradural, 5 epidural, 2 epidural and intradural. Thirty patients underwent a myelography, 10 a computed tomography (CT) scan, and 14 an MRI. Twenty-three spinal angiographies were performed before surgery. Complete removal was achieved in 50 patients (92.6%). Ultrasonic cavitation was used 10 times for debulking the tumor, and laser was used in 12 surgical procedures to perform hemostasis of the meningioma and to coagulate the dural attachment. RESULTS: The majority of the neoplasms were meningothelial (N = 24) or psammomatous (N = 11). No mortality was noted. Morbidity concerned five patients: two pulmonary embolisms, one definitive paraplegia, one transient deficit, and one epidural suppuration, which necessitated a second operation. Mean follow-up was 28 months. Final functional results were very good in 85% and good in 13%; one patient (2%) worsened. Two recurrences were noted: one with clinical signs and the other with only CT-scan modifications. Both patients underwent complementary radiotherapy. DISCUSSION AND CONCLUSION: The authors discuss factors influencing functional results. Sex, pregnancy, pathologic diagnosis, and recurrence do not seem to have any influence. Calcification of the meningioma, as well as an anterior dural attachment, are pejorative factors. They insist on preoperative angiography and point out the advantage of using a CUSA and/or a laser to debulk and coagulate the tumor itself and its dural attachment. They propose radiation therapy as an adjuvant treatment or an alternative to reoperation, which could be hazardous for some patients when, for instance, a recurrence is located in a critical area or when the patient's general status is fragile.

Adolescent↗
PubMed1996

[Development of reconstruction techniques of the anterior skull base after tumor excision].

183 benign and malignant tumors of the anterior cranial base were operated in the department of neurosurgery at Ste Anne's hospital, from June 1982 to December 1993. The bone defect was repaired first with bone sheets taken from the inner table of the cranial flap. Then allografts of irradiated bone and madreporic coral blocks were used as reconstruction material. Since January 1992, no bone reconstruction was performed; the anterior base was just covered with a sheet of Vicryl Composit Mesh (VCM) which was secured bilateraly on the pterion, the temporalis pars squamosa and around the ethmoid defect. This sheet of VCM reinforces the dural plane, which is always lined with a pediculated galea flap. These technical changes and evolution were motivated by: i/- a desire to simplify the surgical technique: ii/- the risk of transmission of viral diseases such as Creutzfeld Jacob disease by allografts, iii/- the frequency of splits and/or falls of madreporic coral grafts. Whatever the material, the infection risks were identical: 8% of subcutaneous and/or deep suppurations, 5% of post-operative meningitis. One patient presented with a transient clinical rhinorrhea.

Bone Transplantation↗
PubMed1996

[Intracavernous invagination of pituitary macro-adenomas].

Depending on authors, intra-cavernous invasion by a pituitary adenoma is found in 9% to 40% of cases. In the light of our own experience, we think that such an invasion is probably much less frequent than usually evoked on CT-scan and MRI. In our study, it was confirmed in only one case over 125 (0.80%), though radiological data suspected an intra-cavernous invasion 17 times. An anatomical study on 20 cadavers showed that 30% of normal pituitary glands present with a lateral expansion into one or both cavernous sinuses (CS). These natural invaginations were already evoked by Harris and Rhoton in 1976. They can resemble an intra-cavernous extension or invasion on MRI views, moreover when an adenoma increases the volume of this expansion, and in the absence of any rupture of the medial wall of the CS. The medial wall of the CS is, in fact, constituted by a dural pouch which close-fits the pituitary gland and its expansions; it invaginates more or less in the CS, depending on the importance of the pituitary lateral expansion. In case of a large adenoma, the finger-glove lateral distension of the pouch disappears progressively during the tumoral removal. Finally the dura returns to its normal place back, at the end of the procedure. This concept of invagination of the CS medial wall, as opposed to that of invasion and therefore of rupture of the dural plane, explains the wide range of figures concerning the frequency of intracavernous invasion by pituitary adenomas, in the literature. These figures are all the more variable as there is no absolute criteria of intra-cavernous invasion on CT-scan nor MRI views. In the same way, no clinical criteria can be retained to assume the existence of such an invasion. So, an ophthalmoplegia seems to be usually linked to a compression of occulomotors nerves; it recovers in a large majority of cases, after the adenoma is removed. In conclusion we emphasize the necessity of interpreting with great care radiological imaging when it evokes' a possible intra-cavernous invasion of a pituitary adenoma. The indication of an eventual radiotherapy should be retained with as much care as possible, since complete removal of an adenoma and its lateral expansion(s) is almost always feasible through a trans-sphenoidal route.

Adenoma↗
PubMed1996

[The Codman Medos programmable shunt valve. Evaluation of 53 implantations in 50 patients].

Fifty three Codman Medos programmable valves were implanted in 50 patients (28 men and 22 women) aged 5 to 77 years, from April 1992 to February 1994. They presented with a hydrocephalus 43 times, an arachnoid cyst three times and a CSF leakage four times. The aims of this study were: a) to test the reliability of this equipment, in current use as well as its eventual advantages, inconveniences and restraints, b) to determine its best indications. Follow-up ranged from 12 to 36 months (average = 22 months). Five patients were lost for follow-up. One patient died from a post-operative sepsis. Four died from their disease. Infectious complications concerned 6 patients (11%). A radio-clinical overdrainage syndrome appeared in 9 patients with slit-ventricles, 5 of them associated with sub-dural collections. All these cases were treated with shunt reprogrammings. While 43 pressure settings over 53 were satisfactory in the immediate post-operative period, it appeared that only 38% of shunts had required one only setting when the study period was over. A certain number of pressure adjustments malfunctioned: 6 times, post-operative X-ray controls showed pressures significantly different from the figures which had been selected (difference from -30 mm H2O to + 70 mm H2O); pressure readjustments were effective and accurate for five of them, but one shunt had to be changed; 15 deprogrammings were detected during long term follow-up, 9 of them after MR1. Pressure programming was readjusted only on patients presenting with clinical signs, i-e mainly for those having a pressure difference > +/-30 mm H2O. As a conclusion, the authors consider that such a shunt can be very useful in some precise indications as: NPH, multioperated hydrocephalus, arachnoid and porencephalic cysts, some spontaneous or iatrogenic CSF leakages, temporary shunts necessitating a progressive withdrawal. Because of a) the cost of this equipment, b) the specific restraints (X-rays controls, programmer), and c) the specific incidents (spontaneous and/or post-MR1 deprogramming), it seems difficult to generalize indications to all cases of hydrocephalus. On the other hand, these shunts have the great advantage of simplifying the treatment of overdrainage by avoiding, in all cases, a reoperation for changing the shunt and/or removing a subdural hematoma. Consequent economies due to a significant diminution of the duration of hospitalisation, could justify an enlargement of indications.

Adolescent↗